Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
34.02
-4.07 (-10.69%)
At close: Apr 28, 2026, 4:00 PM EDT
34.30
+0.28 (0.82%)
After-hours: Apr 28, 2026, 7:40 PM EDT
Qiagen Employees
Qiagen had 5,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$366,666
Profits / Employee
$74,540
Market Cap
7.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5,700 | 0 | - |
| Dec 31, 2024 | 5,700 | -267 | -4.47% |
| Dec 31, 2023 | 5,967 | -211 | -3.42% |
| Dec 31, 2022 | 6,178 | 150 | 2.49% |
| Dec 31, 2021 | 6,028 | 418 | 7.45% |
| Dec 31, 2020 | 5,610 | 514 | 10.09% |
| Dec 31, 2019 | 5,096 | 144 | 2.91% |
| Dec 31, 2018 | 4,952 | 264 | 5.63% |
| Dec 31, 2017 | 4,688 | 4 | 0.09% |
| Dec 31, 2016 | 4,684 | 125 | 2.74% |
| Dec 31, 2015 | 4,559 | 220 | 5.07% |
| Dec 31, 2014 | 4,339 | 324 | 8.07% |
| Dec 31, 2013 | 4,015 | 16 | 0.40% |
| Dec 31, 2012 | 3,999 | 61 | 1.55% |
| Dec 31, 2011 | 3,938 | 351 | 9.79% |
| Dec 31, 2010 | 3,587 | 92 | 2.63% |
| Dec 31, 2009 | 3,495 | 454 | 14.93% |
| Dec 31, 2008 | 3,041 | 379 | 14.24% |
| Dec 31, 2007 | 2,662 | 708 | 36.23% |
| Dec 31, 2006 | 1,954 | 365 | 22.97% |
| Dec 31, 2005 | 1,589 | 267 | 20.20% |
| Dec 31, 2004 | 1,322 | -231 | -14.87% |
| Dec 31, 2003 | 1,553 | -98 | -5.94% |
| Dec 31, 2002 | 1,651 | 94 | 6.04% |
| Dec 31, 2001 | 1,557 | 242 | 18.40% |
| Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 19,700 |
| Revvity | 11,000 |
| Illumina | 10,080 |
| RadNet | 9,276 |
| Medpace Holdings | 6,200 |
| Sotera Health Company | 3,000 |
QGEN News
- 5 hours ago - Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 16 hours ago - Qiagen Transcript: Investor update - Transcripts
- 1 day ago - QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook - Business Wire
- 12 days ago - QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026 - Business Wire
- 14 days ago - QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel - Business Wire
- 4 weeks ago - Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis - Business Wire
- 5 weeks ago - Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Business Wire
- 5 weeks ago - QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention - Business Wire